News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
ana polanco
Biotechnology from around the world comes together in BIOSPAIN 2021 to promote collaboration in a year affected by the Covid-19 crisis
BioSpain
The President of Navarra, María Chivite, states that this sector is strategic for economic recovery…
El avance en la madurez de las start-ups: las fases clínicas
Progress in the maturity of the start-ups: the clinical phases
The start-ups Oxolife, Peptomyc and aptaTargets, with which GENESIS Biomed collaborates, are…
Partners - GENESIS Biomed
team asabys
Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA, is launched with the support of Asabys
Financing
The company is based at the Barcelona Science Park and focuses on the discovery of new drugs…
Partners - Asabys Partners
Algenex Crisbio
Algenex’ CrisBio® platform validated by EU and UK marketing authorization for CrisBio-based vaccine for Rabbit Viral Haemorrhagic Disease
Animal health
Algenex SL and FATRO S.p.A, a leader in the field of veterinary pharmaceutical products, have…
Partners - Algenex
Grgory Rall
#InterviewBiospain2021 | "Biospain will allow us all to reach more Spanish biomedical talents"
BioSpain
Gregory Rall, Senior Manager of Innovation and Technology at Invest HK, bronze sponsor of Biospain…
oryzon
ORYZON to present new clinical data and corporate updates at international conferences in September and October
Healthcare · BioSpain
International Conference on Autism ICA-2021 BIOSPAIN 2021 34th European College…
Partners - Oryzon Genomics
foto alzheimer
Report | The incredible challenge of diagnosing a silent disease: Alzheimer's
Healthcare · In vitro diagnostics · Personalized medicine
To mark World Alzheimer's Day, we spoke to Marta Barrachina, founder and CEO of ADmit Therapeutics,…
AseBio - ADmit Therapeutics
oryzon
Oryzon announces $1 million grant from Kabuki syndrome philanthropists to support a precision medicine Phase I/II trial with vafidemstat
Healthcare
HOPE will be the first clinical trial in precision medicine with vafidemstat in…
Partners - Oryzon Genomics
divertisty
Ysios Capital achieves Certification under the Diversity VC Standard
Financing
Ysios Capital is the first specialized venture capital firm in life sciences globally and the first…
Partners - Ysios Capital Partners